Home › Funds › Fairmount Funds Management LLC › ORKA

Fairmount Funds Management LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Fairmount Funds Management LLC reported holding 3,705,262 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$352.6M, representing 23.31% of its reported portfolio and ranking #1 among its reported holdings. Fairmount Funds Management LLC has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)3.71M sh
Reported value held$352.63M
Portfolio Weight23.31%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Fairmount Funds Management LLC's ORKA position evolved

Fairmount Funds Management LLC first disclosed a stake in ORKA in Q3 2024 at 3,211,922 shares (US$78.7M). The position peaked in Q2 2026 at 3,705,262 shares, worth US$352.6M. Across 8 filings, Fairmount Funds Management LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,705,262 shares valued at US$352.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.21M $78.72M New
Q4 2024 3.37M $65.38M Add
Q1 2025 3.37M $34.60M Hold
Q2 2025 3.37M $37.80M Hold
Q3 2025 3.71M $71.25M Add
Q4 2025 3.71M $112.31M Hold
Q1 2026 3.71M $181.74M Hold
Q2 2026 3.71M $352.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), RTW INVESTMENTS, LP (US$298.7M), Paradigm Biocapital Advisors LP (US$204.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Fairmount Funds Management LLC held ORKA?

Fairmount Funds Management LLC has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Fairmount Funds Management LLC's current position in ORKA?

As of Q2 2026, Fairmount Funds Management LLC holds 3.71M shares of ORKA (ORUKA THERAPEUTICS INC), valued at $352.63M, representing 23.31% of its reported portfolio and ranking #1.

Has Fairmount Funds Management LLC been buying or selling ORKA?

In the latest 13F filing (Q2 2026), Fairmount Funds Management LLC held unchanged its position in ORKA. The position peaked in Q2 2026 at 3.71M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.